Kapitansky, Oxana
Giladi, Eliezer
Jaljuli, Iman
Bereswill, Stefan
Heimesaat, Markus M.
Gozes, Illana http://orcid.org/0000-0001-9796-2430
Funding for this research was provided by:
National Science Foundation (BSF-NSF 2016746)
BMBF (IP7/ 01KI1725D)
ERA-NET (ADNPinMED)
Article History
Received: 26 December 2019
Accepted: 20 January 2020
First Online: 18 February 2020
Compliance with ethical standards
:
: Professor Illana Gozes serves as the Chief Scientific Officer of Coronis Neurosciences developing CP201 for the ADNP syndrome. Microbiome changes as a consequence of the ADNP syndrome are under patent protection.